Section

Divi's Laboratories Q3 Results: Pharma major sees 17% jump in profit to Rs 358 crore

By Business Today - 10 months ago
Operational performance was on the weaker side as the company's earnings before interest, taxes, depreciation and amortization (EBITDA) came in at Rs 479 crore, up around 19.6 percent from Rs 409 crore.  

Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.